| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 14th January 2021 | David J Mazzo | 5,936 | Payment by withholding | $1.56 | $9,260.16 |
| 13th January 2021 | David J Mazzo | 6,425 | Payment by withholding | $1.55 | $9,958.75 |
| 13th January 2021 | David J Mazzo | 39,000 | Grant/award etc. | $0.00 | |
| 13th January 2021 | David J Mazzo | 21,787 | Payment by withholding | $1.55 | $33,769.85 |
| 9th September 2020 | Michael H. Davidson | 55,525 | Open or private purchase | $1.80 | $99,945.00 |
| 28th July 2020 | Michael H. Davidson | 51,063 | Grant/award etc. | $2.35 | $119,998.05 |
| 12th March 2020 | Cynthia Schwalm | 21,693 | Open or private purchase | $3.24 | $70,285.32 |
| 12th March 2020 | Cynthia Schwalm | 9,307 | Open or private purchase | $3.24 | $30,108.15 |
| 14th January 2020 | Douglas W Losordo | 2,190 | Payment by withholding | $3.38 | $7,402.20 |
| 14th January 2020 | Joseph Talamo | 2,190 | Payment by withholding | $3.38 | $7,402.20 |
Caladrius Biosciences
Caladrius Biosciences, Inc. is a biopharmaceutical company. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ.
Ticker: CLBS
Sector: Distribution Services
Industry: Wholesale Distributors
SEC Central Index Key (CIK): 320017
Employees: 27
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
